SUBSCRIBE
SUBSCRIBE

Shinobi Therapeutics

NEWS
NextGen
BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
 · 
5 min read
 · 
Heather McKenzie
IN THE PRESS
Business
Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology
May 30, 2024
 · 
4 min read
Business
Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology
April 18, 2024
 · 
3 min read
Biotech Bay
Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform
December 12, 2023
 · 
5 min read
AWARDS
  • NextGen Class of 2025
JOBS